Trial intelligence / Profile preview

XYLA cream versus lidocaine injection for episiotomy pain

IRCT20160830029608N2Phase 3Completed

Sponsor
Fasa University of Medical Sciences
Start
Jul 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, single-blind trial of lidocaine in episiotomy (2 arms), sponsored by Fasa University of Medical Sciences. Primary endpoint: Reduction of episiotomy pain. Started Jul 2017; status: completed.

02

Drugs

lidocaine
03

Conditions

episiotomy

Beyond the preview

Go deeper on IRCT20160830029608N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20160830029608N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call